Szepeshazi K - Search Results

1

Antagonists of growth hormone-releasing hormone inhibit the proliferation of experimental non-small cell lung carcinoma.

Szereday Z, Schally AV, Varga JL, Kanashiro CA, Hebert F, Armatis P, Groot K, Szepeshazi K, Halmos G, Busto R. Szereday Z, et al. Among authors: szepeshazi k. Cancer Res. 2003 Nov 15;63(22):7913-9. Cancer Res. 2003. PMID: 14633721

2

Targeted cytotoxic somatostatin analogue AN-238 inhibits somatostatin receptor-positive experimental colon cancers independently of their p53 status.

Szepeshazi K, Schally AV, Halmos G, Armatis P, Hebert F, Sun B, Feil A, Kiaris H, Nagy A. Szepeshazi K, et al. Cancer Res. 2002 Feb 1;62(3):781-8. Cancer Res. 2002. PMID: 11830533

3

Bombesin antagonists inhibit growth of MDA-MB-435 estrogen-independent breast cancers and decrease the expression of the ErbB-2/HER-2 oncoprotein and c-jun and c-fos oncogenes.

Bajo AM, Schally AV, Krupa M, Hebert F, Groot K, Szepeshazi K. Bajo AM, et al. Among authors: szepeshazi k. Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3836-41. doi: 10.1073/pnas.052715299. Epub 2002 Mar 12. Proc Natl Acad Sci U S A. 2002. PMID: 11891317 Free PMC article.

4

The expression of growth hormone-releasing hormone (GHRH) and splice variants of its receptor in human gastroenteropancreatic carcinomas.

Busto R, Schally AV, Varga JL, Garcia-Fernandez MO, Groot K, Armatis P, Szepeshazi K. Busto R, et al. Among authors: szepeshazi k. Proc Natl Acad Sci U S A. 2002 Sep 3;99(18):11866-71. doi: 10.1073/pnas.182433099. Epub 2002 Aug 19. Proc Natl Acad Sci U S A. 2002. PMID: 12186980 Free PMC article.

5

Effective treatment of H838 human non-small cell lung carcinoma with a targeted cytotoxic somatostatin analog, AN-238.

Szereday Z, Schally AV, Szepeshazi K, Bajo AM, Hebert F, Halmos G, Nagy A. Szereday Z, et al. Among authors: szepeshazi k. Int J Oncol. 2003 May;22(5):1141-6. Int J Oncol. 2003. PMID: 12684683

6

Preclinical evaluation of therapeutic effects of targeted cytotoxic analogs of somatostatin and bombesin on human gastric carcinomas.

Szepeshazi K, Schally AV, Nagy A, Wagner BW, Bajo AM, Halmos G. Szepeshazi K, et al. Cancer. 2003 Oct 1;98(7):1401-10. doi: 10.1002/cncr.11649. Cancer. 2003. PMID: 14508826 Free article.

7

Preclinical evaluation of targeted cytotoxic luteinizing hormone-releasing hormone analogue AN-152 in androgen-sensitive and insensitive prostate cancers.

Letsch M, Schally AV, Szepeshazi K, Halmos G, Nagy A. Letsch M, et al. Among authors: szepeshazi k. Clin Cancer Res. 2003 Oct 1;9(12):4505-13. Clin Cancer Res. 2003. PMID: 14555524

8

Inhibitory effect of antagonists of bombesin and growth hormone-releasing hormone on orthotopic and intraosseous growth and invasiveness of PC-3 human prostate cancer in nude mice.

Stangelberger A, Schally AV, Varga JL, Zarandi M, Szepeshazi K, Armatis P, Halmos G. Stangelberger A, et al. Among authors: szepeshazi k. Clin Cancer Res. 2005 Jan 1;11(1):49-57. Clin Cancer Res. 2005. PMID: 15671527

9

Targeted chemotherapy with cytotoxic bombesin analogue AN-215 inhibits growth of experimental human prostate cancers.

Stangelberger A, Schally AV, Letsch M, Szepeshazi K, Nagy A, Halmos G, Kanashiro CA, Corey E, Vessella R. Stangelberger A, et al. Among authors: szepeshazi k. Int J Cancer. 2006 Jan 1;118(1):222-9. doi: 10.1002/ijc.21292. Int J Cancer. 2006. PMID: 16003723

10

Inhibition of growth of experimental human and hamster pancreatic cancers in vivo by a targeted cytotoxic bombesin analog.

Szepeshazi K, Schally AV, Nagy A, Halmos G. Szepeshazi K, et al. Pancreas. 2005 Oct;31(3):275-82. doi: 10.1097/01.mpa.0000175892.97036.a7. Pancreas. 2005. PMID: 16163060

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

106 results

Search Page

Filters